Clinical trials
Asthma Patients clinical trials
Below are recruiting asthma patients clinical trials, each written for real people, not researchers. We’re tracking 69 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06441812RecruitingPhase 2
Long-term safety of a new asthma medicine
This trial tests a new medicine called SHR-1703 for people with eosinophilic asthma (a type of asthma with high levels of certain white blood cells). It looks at how safe the medicine is over time and if it helps control asthma attacks. You must already be using medium or high dose inhaled steroids plus another asthma medicine, and have had at least one asthma attack in the past year.
Chengdu, SichuanAges 18 years+ - NCT07489911Recruiting
Real-world study of triple inhaler for uncontrolled asthma
This study tests a triple-inhaler called Trimbow for people whose asthma is not well controlled despite using other inhalers. The goal is to see if switching to Trimbow helps reduce asthma attacks and improve day-to-day breathing.
CeljeAges 18 years+ - NCT06766136Recruiting
Asthma education program based on the Roy Adaptation Model
This trial tests a new asthma education program designed to help you better manage your asthma symptoms and improve your quality of life. The program is based on the Roy Adaptation Model, which focuses on helping you adapt to your condition.
Niğde, CenterAges 18–64 - NCT07110116Recruiting
Breathing exercises with a spirometer for asthma patients
This trial tests whether combining alternate nostril breathing with an incentive spirometer improves lung function in people with asthma. It may help you breathe better if your asthma is mild to moderate and stable.
Abbottābād, Khyber PkahtoonKhwaAges 18–60 - NCT07342803RecruitingPhase 2
LP-003 injection for allergic asthma
This trial tests an injection called LP-003 for people with allergic asthma that is not well controlled by current inhalers and other medications. It aims to see if the drug can improve asthma control and reduce flare-ups.
ShanghaiAges 18–75 - NCT05364632Recruiting
Exercise training to improve activity in people with asthma
This trial compares an aerobic exercise program with a behavioral program to help increase physical activity in people with asthma. It may help you build safer activity habits, especially if your asthma symptoms are not well controlled.
São Paulo, São PauloAges 18–65 - NCT07015749RecruitingPhase 1
IBI3002 for moderate to severe asthma
This trial tests a new drug called IBI3002 for people with moderate to severe asthma that isn't well controlled with standard inhalers. It aims to see if the drug is safe and tolerable when given multiple times.
Suzhou, JiangsuAges 18–65 - NCT05525169Recruiting
Study how indoor and outdoor pollution affects asthma
This study looks at whether exposure to air pollution inside and outside your home affects asthma symptoms and flare-ups. You may be asked to use sensors at home to measure pollution levels and link them to your asthma over time.
NantesAges 18–99 - NCT07665892RecruitingPhase 1
Testing a new asthma drug in adults
This study tests a new medication called ASY202 for adults with stable asthma. The goal is to see if it's safe and how the body processes it. It may be an option for those who have not had a recent asthma attack or infection.
Glendale, ArizonaAges 18–55 - NCT06216535RecruitingPhase 2
Escitalopram for frequent asthma attacks
This study tests whether the antidepressant escitalopram can reduce asthma attacks in people who have frequent, severe flare-ups despite using their regular inhalers. It may help if you have moderate to severe asthma and have had 3 or more attacks needing steroids in the past year.
Dallas, TexasAges 18–75 - NCT06456450Recruiting
Taiwan severe asthma biologic registry study
This study is creating a registry to track the long-term safety and effectiveness of biologic treatments for severe asthma in Taiwan. If you are taking a biologic like omalizumab, mepolizumab, or benralizumab, joining this registry helps doctors learn how well these medicines work over time.
TaichungAges 18 years+ - NCT06116292Recruiting
Telemedicine program for adults with asthma
This study tests a telemedicine program (through a mobile app) for adults with asthma. It aims to see if the program helps improve asthma management and quality of life.
Barcelona, BarcelonaAges 18 years+ - NCT07529847Recruiting
Breathing Techniques to Help Asthma Control
This study compares two special breathing techniques—alternating which nostril you breathe through and a method called Buteyko breathing—to see which helps asthma patients breathe easier and improve lung function. You'll practice these techniques and we'll measure how well they work for you.
IslamabadAges 18–45 - NCT02241265Recruiting
Testing how lung breathing tests respond to bronchial treatment
This trial looks at how lung function test results change after bronchial thermoplasty in adults with severe asthma. It may help doctors understand who benefits from this procedure based on breathing test measures.
Oklahoma City, OklahomaAges 18–99 - NCT06323213RecruitingPhase 3
Testing a new asthma medicine for severe asthma
This study tests an experimental drug called 610 for people with severe asthma that is not well-controlled with standard medicines. The goal is to see if adding 610 can improve asthma control and reduce flare-ups.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07713498Enrolling by invitation
Lowering inhaled steroids for tezepelumab-treated asthma patients
This trial looks at whether people with severe asthma who are taking the biologic tezepelumab can safely reduce their use of inhaled corticosteroids (ICS). It aims to see if reducing or stopping ICS affects asthma symptoms or flare-ups.
Rotterdam, South HollandAges 18 years+ - NCT06015256Recruiting
Natural killer cells in severe asthma patients
This study looks at immune cells called natural killer cells in people with severe asthma. Researchers want to see how these cells are different in people whose asthma is well-controlled, not well-controlled, or flaring up, compared to healthy volunteers without asthma.
MarseilleAges 18 years+ - NCT06908421Recruiting
Smart device and inhaler for better asthma control
This study tests if using a small smart device with your Trimbow inhaler helps you use it correctly and take it as prescribed. It is for people with asthma who already use Trimbow.
Hvidovre, Capital RegionAges 18 years+ - NCT07532265RecruitingPhase 2
Testing a New Drug for Hard-to-Control Asthma
This study tests whether a new drug called frevecitinib can help people with severe asthma that isn't well controlled even with strong inhaled steroid medications. The goal is to see if it reduces asthma attacks and improves breathing.
Lancaster, CaliforniaAges 18–75 - NCT06637254Enrolling by invitationPhase 2
Testing an oral tablet for hard-to-control asthma
This study tests an oral tablet (HSK31858) to see if it helps control asthma in people whose asthma is not well managed with current inhalers. It focuses on those with a specific type of asthma where certain blood cells are low.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT05364957Recruiting
Gastric balloon plus asthma care for uncontrolled asthma and obesity
This study tests whether placing a soft “balloon” inside the stomach (intragastric balloon) can help people who have uncontrolled asthma and obesity. It also checks whether the balloon is safe and can improve asthma control when standard inhaler treatment is already in use.
Toulouse, OccitanieAges 18–65 - NCT06137040RecruitingEarly Phase 1
Early IV Magnesium for Moderate Asthma in Children
This trial tests whether giving magnesium sulfate through an IV early in the emergency room helps children aged 5–17 who are having a moderate asthma attack. It aims to improve breathing and reduce the need for hospital stays.
Oklahoma City, OklahomaAges 5–17 - NCT07396987Recruiting
Improving asthma specialist referrals for emergency room patients
This study looks at whether a new approach can help more people get connected with asthma specialists after an emergency room visit. If you have asthma and recently went to the ER, this trial may help you get expert follow-up care to better manage your condition.
Tampa, FloridaAges 18 years+ - NCT07168473RecruitingPhase 3
A study of DW1807 for year-round allergies and asthma
This trial tests a new medicine called DW1807 for people who have both year-round allergies (like dust mites or pet dander) and asthma. It aims to see if it helps control nasal symptoms and is safe to use.
SeoulAges 19 years+
Hear when a new Asthma Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for asthma patients?
- Yes. Clin2 currently lists 69 recruiting asthma patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a asthma patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a asthma patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.